"Lipoproteins, IDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mixture of very-low-density lipoproteins (VLDL), particularly the triglyceride-poor VLDL, with slow diffuse electrophoretic mobilities in the beta and alpha2 regions which are similar to that of beta-lipoproteins (LDL) or alpha-lipoproteins (HDL). They can be intermediate (remnant) lipoproteins in the de-lipidation process, or remnants of mutant CHYLOMICRONS and VERY-LOW-DENSITY LIPOPROTEINS which cannot be metabolized completely as seen in FAMILIAL DYSBETALIPOPROTEINEMIA.
| Descriptor ID |
D053419
|
| MeSH Number(s) |
D10.532.473 D12.776.521.514
|
| Concept/Terms |
Lipoproteins, IDL- Lipoproteins, IDL
- IDL Lipoproteins
- Lipoproteins, Intermediate Density
- Lipoprotein, IDL
- IDL Lipoprotein
- Intermediate Density Lipoproteins
- Intermediate-Density Lipoproteins
- Lipoproteins, Intermediate-Density
alpha2-Very-Low-Density Lipoproteins- alpha2-Very-Low-Density Lipoproteins
- Lipoproteins, alpha2-Very-Low-Density
- alpha2 Very Low Density Lipoproteins
- alpha2-VLDL Lipoprotein
- Lipoprotein, alpha2-VLDL
- alpha2 VLDL Lipoprotein
- alpha2-VLDL
- alpha2 VLDL
|
Below are MeSH descriptors whose meaning is more general than "Lipoproteins, IDL".
Below are MeSH descriptors whose meaning is more specific than "Lipoproteins, IDL".
This graph shows the total number of publications written about "Lipoproteins, IDL" by people in this website by year, and whether "Lipoproteins, IDL" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lipoproteins, IDL" by people in Profiles.
-
High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study. Lipids Health Dis. 2011 Oct 18; 10:181.
-
Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia. J Lipid Res. 2010 Jun; 51(6):1524-34.
-
Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2009 Sep; 29(9):1349-55.
-
A neuronal VLDLR variant lacking the third complement-type repeat exhibits high capacity binding of apoE containing lipoproteins. Brain Res. 2009 Jun 18; 1276:11-21.
-
Nicotinic acid: a new look at an old drug. Curr Atheroscler Rep. 2009 Mar; 11(2):87-92.